category: pyridazine, The prevalence of solvent effects in heterogeneous catalysis in condensed media has motivated developing quantitative kinetic and theoretical assessments of solvent structures and their interactions with reaction intermediates and transition states.
The present invention provides a hepatitis c inhibitor spiro compound and its use in medicine. The compound of formula (I) compound shown by the formula (I) as shown in the stereo isomers, geometric isomers, tautomers, nitrogen oxide, hydrate, solvate, metabolite, pharmaceutically acceptable salt or prodrug. In addition, the invention also provides a pharmaceutical composition, said compound and said pharmaceutical composition for inhibiting HCV replication and inhibit HCV virus protein function of at least one of the use, and the compounds and pharmaceutical composition useful for the prevention, treatment, treatment or alleviation of patient’s HCV infection or hepatitis c treatment of diseases. (by machine translation)
Therefore, this conceptually novel strategy might open impressive avenues to establish green and sustainable chemistry platforms.In my other articles, you can also check out more blogs about 89284-10-6category: pyridazine, you can also check out more blogs aboutcategory: pyridazine
Reference：
Pyridazine – Wikipedia,
Pyridazine | C4H4N3143 – PubChem